Safety of baricitinib in vaccinated patients with severe and critical COVID-19 sub study of the randomised Bari-SolidAct trial.

Viermyr HK, Tonby K, Ponzi E, Trouillet-Assant S, Poissy J, Arribas JR, Dyon-Tafani V, Bouscambert-Duchamp M, Assoumou L, Halvorsen B, Tekin NB, Diallo A, De Gastines L, Munthe LA, Murphy SL, Ueland T, Michelsen AE, Lund-Johansen F, Aukrust P, Mootien J, Dervieux B, Zerbib Y, Richard JC, Prével R, Malvy D, Timsit JF, Peiffer-Smadja N, Roux D, Piroth L, Ait-Oufella H, Vieira C, Dalgard O, Heggelund L, Müller KE, Møller JH, Kildal AB, Skogen V, Aballi S, Sjøberg Øgaard JD, Dyrhol-Riise AM, Tveita A, Alirezaylavasani A, Costagliola D, Yazdanpanah Y, Olsen IC, Dahl TB, Kared H, Holten AR, Trøseid M.

Open source

DOI
10.1016/j.ebiom.2024.105511
Published
2024-12-27
Container
EBioMedicine
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ebiom.2024.105511,
  title = {Safety of baricitinib in vaccinated patients with severe and critical COVID-19 sub study of the randomised Bari-SolidAct trial.},
  author = {Viermyr HK and  Tonby K and  Ponzi E and  Trouillet-Assant S and  Poissy J and  Arribas JR and  Dyon-Tafani V and  Bouscambert-Duchamp M and  Assoumou L and  Halvorsen B and  Tekin NB and  Diallo A and  De Gastines L and  Munthe LA and  Murphy SL and  Ueland T and  Michelsen AE and  Lund-Johansen F and  Aukrust P and  Mootien J and  Dervieux B and  Zerbib Y and  Richard JC and  Prével R and  Malvy D and  Timsit JF and  Peiffer-Smadja N and  Roux D and  Piroth L and  Ait-Oufella H and  Vieira C and  Dalgard O and  Heggelund L and  Müller KE and  Møller JH and  Kildal AB and  Skogen V and  Aballi S and  Sjøberg Øgaard JD and  Dyrhol-Riise AM and  Tveita A and  Alirezaylavasani A and  Costagliola D and  Yazdanpanah Y and  Olsen IC and  Dahl TB and  Kared H and  Holten AR and  Trøseid M.},
  year = {2025},
  journal = {EBioMedicine},
  doi = {10.1016/j.ebiom.2024.105511},
  url = {https://doi.org/10.1016/j.ebiom.2024.105511}
}

RIS

TY  - JOUR
TI  - Safety of baricitinib in vaccinated patients with severe and critical COVID-19 sub study of the randomised Bari-SolidAct trial.
AU  - Viermyr HK
AU  -  Tonby K
AU  -  Ponzi E
AU  -  Trouillet-Assant S
AU  -  Poissy J
AU  -  Arribas JR
AU  -  Dyon-Tafani V
AU  -  Bouscambert-Duchamp M
AU  -  Assoumou L
AU  -  Halvorsen B
AU  -  Tekin NB
AU  -  Diallo A
AU  -  De Gastines L
AU  -  Munthe LA
AU  -  Murphy SL
AU  -  Ueland T
AU  -  Michelsen AE
AU  -  Lund-Johansen F
AU  -  Aukrust P
AU  -  Mootien J
AU  -  Dervieux B
AU  -  Zerbib Y
AU  -  Richard JC
AU  -  Prével R
AU  -  Malvy D
AU  -  Timsit JF
AU  -  Peiffer-Smadja N
AU  -  Roux D
AU  -  Piroth L
AU  -  Ait-Oufella H
AU  -  Vieira C
AU  -  Dalgard O
AU  -  Heggelund L
AU  -  Müller KE
AU  -  Møller JH
AU  -  Kildal AB
AU  -  Skogen V
AU  -  Aballi S
AU  -  Sjøberg Øgaard JD
AU  -  Dyrhol-Riise AM
AU  -  Tveita A
AU  -  Alirezaylavasani A
AU  -  Costagliola D
AU  -  Yazdanpanah Y
AU  -  Olsen IC
AU  -  Dahl TB
AU  -  Kared H
AU  -  Holten AR
AU  -  Trøseid M.
PY  - 2025
JO  - EBioMedicine
DO  - 10.1016/j.ebiom.2024.105511
UR  - https://doi.org/10.1016/j.ebiom.2024.105511
ER  -

APA

HK, V., K, T., E, P., S, T., J, P., JR, A., V, D., M, B., L, A., B, H., NB, T., A, D., L, D. G., LA, M., SL, M., T, U., AE, M., F, L., P, A., J, M., B, D., Y, Z., JC, R., R, P., D, M., JF, T., N, P., D, R., L, P., H, A., C, V., O, D., L, H., KE, M., JH, M., AB, K., V, S., S, A., JD, S. Ø., AM, D., A, T., A, A., D, C., Y, Y., IC, O., TB, D., H, K., AR, H., & M., T. (2025). Safety of baricitinib in vaccinated patients with severe and critical COVID-19 sub study of the randomised Bari-SolidAct trial.. EBioMedicine. https://doi.org/10.1016/j.ebiom.2024.105511

Source records